首页> 外国专利> 3-(4-nitrophenyl)-4-(pyridyn-2-yl)-4,5-dihydro-1H-1,2,4-triazole-5-thione and method for obtaining it and pharmaceutical composition

3-(4-nitrophenyl)-4-(pyridyn-2-yl)-4,5-dihydro-1H-1,2,4-triazole-5-thione and method for obtaining it and pharmaceutical composition

机译:3-(4-硝基苯基)-4-(吡啶-2-基)-4,5-二氢-1H-1,2,4-三唑-5-硫酮及其获得方法和药物组合物

摘要

the object of the application is a new 3 - (4-nitrophenyl) - 4 - (pyridin-2-yl) - 4,5 - dihydro 1h 1,2,4 triazolo - 5 - mutation (model 1) and the way to obtain, which is a reaction cyklizacji 4 - (4-nitrophenyl) - 1 - (pyridin - 2 - karbonylotio yl) - semicarbazide (model 2) in a solution of 2% of sodium hydroxide.the mixture is heated in september for about 2 hours, and the sludge is obtained by wytracenie by 3m hcl. the 4 - (4-nitrophenyl) - 4 - (pyridin-2-yl) - 4,5 - dihydro 1h 1,2,4 triazolo - 5 - mutation (model 1) crystallizes, preferably with methanol.which is also the subject of pharmaceutical composition contains as an active ingredient compound 3 - (4-nitrophenyl) - 4 - (pyridin-2-yl) - 4,5 - dihydro 1h 1,2,4 triazolo - 5 - mutation.
机译:本申请的目的是一个新的3-(4-硝基苯基)-4-(吡啶-2-基)-4,5-二氢1h 1,2,4三唑-5-突变(模型1)及其制备方法得到的是在2%的氢氧化钠溶液中的cyklizacji 4--(4-硝基苯基)-1-(吡啶-2-karbonylotio yl)-氨基脲(模型2)的反应。混合物在9月加热约2小时,并且wytracenie以3m hcl的速度获得了污泥。 4-(4-硝基苯基)-4-(吡啶-2-基)-4,5-二氢1h 1,2,4三唑-5-突变(模型1)结晶,最好用甲醇结晶。药物组合物含有作为活性成分的化合物3-(4-硝基苯基)-4-(吡啶-2-基)-4,5-二氢1h 1,2,4三唑-5-突变。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号